Educational Session 13: The Evolving Role of Neoadjuvant Endocrine Therapy 

Moderator

Erika Hamilton, Sarah Cannon Research Institute, Nashville, TN

Presentation numberED13-01

Neoadjuvant Endocrine Therapy: What Have We Learned In the Past 20 Years.

Harold Burstein, Dana-Farber Cancer Institute, Boston, MA

Presentation numberED13-02

Redefining Response: Beyond pCR to Complementary Biologic Endpoints

Cynthia X Ma

Presentation numberED13-03

Neoadjuvant Endocrine Therapy as a Tool for Personalizing Surgical Management

Taiwo Adesoye

Advocate

Sharon Rivera-Sanchez